Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
26.83
-0.70 (-2.54%)
At close: Oct 10, 2025, 4:00 PM EDT
26.50
-0.33 (-1.23%)
After-hours: Oct 10, 2025, 7:59 PM EDT
Moderna Revenue
Moderna had revenue of $142.00M in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.36
Revenue / Employee
$530,690
Employees
5,800
Market Cap
10.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MRNA News
- 13 days ago - 3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha
- 17 days ago - Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript - Seeking Alpha
- 18 days ago - Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK - Accesswire
- 18 days ago - Moderna: Maintaining Sell Despite Consolidation - And Why MRNY Won't Help Either - Seeking Alpha
- 19 days ago - Moderna says updated next-generation COVID shot shows strong immune response in patients - Reuters
- 19 days ago - Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans - Accesswire
- 23 days ago - Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories - Accesswire
- 26 days ago - Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans - Accesswire